Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

DiaSorin Molecular LLC

US

Last updated September 17, 2026

About

Diasorin is the global leader in Molecular Diagnostics and Immunodiagnostics market. Discover all Diasorin’s diagnostic solutions.

From the manufacturer's own website. Source

Information

Country
US
Address
11331 Valley View St, CYPRESS, CA, 90630
Email
—
Phone
—
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
2023365
DUNS Number
—

Catalogue (108)

Page 1 of 3
DeviceModel / ReferenceRegistriesClassStatus
West Nile Virus IgM Capture DxSelect™ EL0300M-5
FDA UDI
Class IIActive
Simplexa™ C. auris Sample Prep Kit MOL5390
FDA UDI
Class IIActive
IgM Capture Wells EL1521
FDA UDI
Class IIActive
Simplexa™ VZV Direct MOL3650
FDA UDI
Class IIActive
Simplexa™ C.difficile Sample Prep Kit MOL5290
FDA UDI
Class IIActive
Simplexa™ Flu A/B & RSV MOL2600
FDA UDI
Class IIActive
HerpeSelect® 1 and 2 Immunoblot IgG IB0900G
FDA UDI
Class IIActive
Measles Virus Primer Pair MOL9207
FDA UDI
Class IActive
HSV-1 ELISA IgG Conjugate EL0916
FDA UDI
Class IIActive
HSV-2 ELISA IgG High Positive Control EL0908
FDA UDI
Class IIActive
Direct Amplification Disc MOL1451
FDA UDI
Class IIActive
Universal Disc MOL1401
FDA UDI
Class IIActive
West Nile Virus IgG DxSelect™ - IgG Conjugate EL0304
FDA UDI
Class IIActive
Simplexa™ C. difficile Direct MOL2950
FDA UDI
Class IIActive
Simplexa™ VZV Positive Control Pack MOL3660
FDA UDI
Class IIActive
Simplexa COVID-19 Positive Control GEN II Pack MOL4165
FDA UDI
Class IIActive
HSV-1 AND HSV-2 Differentiation Immunoblot IgG Antigen Strips IB0901
FDA UDI
Class IIActive
HSV-1 ELISA IgG Low Positive Control EL0906
FDA UDI
Class IIActive
Direct Amplification Disc MOL1451
FDA UDI
Class IIActive
Monkeypox Primer Pair MOL9202
FDA UDI
Class IActive
HSV ELISA Negative Control EL0904
FDA UDI
Class IIActive
Legionella IFA Non-Detectable Control IF0913
FDA UDI
Class IIUnknown
DxSelect™ Amber Sample Diluent EL1708
FDA UDI
Class IIUnknown
Legionella IFA Substrate Slides IF0951
FDA UDI
Class IIUnknown
Human GAPDH Endogenous Primer Pair MOL9178
FDA UDI
Class IActive
Simplexa™ GBS Direct MOL3550
FDA UDI
Class IIActive
Simplexa™ C. auris Positive Control Pack MOL3960
FDA UDI
Class IIActive
Simplexa™ Bordetella Direct MOL2750
FDA UDI
Class IIUnknown
HSV-1 ELISA IgG Cutoff Calibrator EL0903
FDA UDI
Class IIActive
Simplexa™ HSV 1 & 2 Direct MOL2150
FDA UDI
Class IIActive
Simplexa™ VZV Swab Direct MOL3655
FDA UDI
Class IIActive
Integrated Cycler (220V) Pre-Owned MOL1011-P
FDA UDI
Class IIActive
Simplexa Congenital CMV Direct MOL2255
FDA UDI
Class IIActive
Simplexa™ C. auris Direct MOL3950
FDA UDI
Class IIActive
Simplexa™ Group A Strep Direct MOL2850
FDA UDI
Class IIActive
Histoplasma DxSelect™ EL1700
FDA UDI
Class IIUnknown
Simplexa COVID-19 Positive Control Pack MOL4160
FDA UDI
Class IIActive
HSV-2 ELISA IgG Conjugate EL0917
FDA UDI
Class IIActive
West Nile Virus IgM Capture DxSelect™ Antigen EL0322
FDA UDI
Class IIActive
West Nile Virus DxSelect™ Negative Control EL0312
FDA UDI
Class IIActive
Simplexa™ Spectral Calibration Panel SC1100
FDA UDI
N/AActive
HSV-2 IgG Antigen Wells EL0902
FDA UDI
Class IIActive
Universal Disc MOL1400
FDA UDI
Class IIActive
Legionella IFA Detectable Control IF0914
FDA UDI
Class IIUnknown
Simplexa™ Flu A/B & RSV Positive Control Pack MOL2660
FDA UDI
Class IIActive
Simplexa™ C. difficile Universal Direct MOL2975
FDA UDI
Class IActive
Stratify Jcv™ Dxselect™ EL1950-5
FDA UDI
Class IIActive
Simplexa Congenital CMV Positive Control Pack MOL2265
FDA UDI
Class IIActive
Integrated Cyler (110V) Pre-Owned MOL1001-P
FDA UDI
Class IIActive
Simplexa™ HSV 1 & 2 Positive Control Pack MOL2160
FDA UDI
Class IIActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (8)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

DateRecall No.ClassStatusReason
Jun 14, 2023Z-2153-2023—open, classified

There is a potential for the direct amplification disc to malfunction which may result in spillage of liquid from the disc.

Jan 30, 2023Z-1210-2023—open, classified

Direct amplification Discs , used with COVID-19 and Flu A/B & RSV assays, may leak and cause contamination, cross-contamination, invalid results, and error codes.

Jan 30, 2023Z-1209-2023—open, classified

Direct amplification Discs , used with COVID-19 and Flu A/B & RSV assays, may leak and cause contamination, cross-contamination, invalid results, and error codes.

Nov 19, 2021Z-0457-2022—open, classified

A subset of affected discs are at risk of leakage when it is used more than one time with Simplexa COVID-19 Direct and/or Simplexa Flu A/B & RSV Direct Gen II. Leakage from a well that had a positive sample may cause further cross-contamination in areas of the lab if not properly cleaned.

Sep 23, 2021Z-0162-2022—open, classified

Due to unapproved raw materials used in the manufacturing of Covid-19 control pack, their is the potential for delayed amplification signals.

May 12, 2020Z-2547-2020—terminated

Due to a software malfunction in the Multi Assay Suite, there is the probability of increased occurrence of false negative results.

May 12, 2020Z-2549-2020—terminated

Due to a software malfunction in the Multi Assay Suite, there is the probability of increased occurrence of false negative results.

May 12, 2020Z-2548-2020—terminated

Due to a software malfunction in the Multi Assay Suite, there is the probability of increased occurrence of false negative results.